Detalhe da pesquisa
1.
MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL.
Br J Haematol
; 184(6): 925-936, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537114
2.
Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
Br J Haematol
; 163(2): 182-93, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23927424
3.
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors.
Blood
; 117(12): 3421-9, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21233313
4.
Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.
Cancer Cell
; 34(6): 982-995.e7, 2018 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30503705
5.
Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study.
PLoS One
; 13(3): e0193249, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29513759
6.
Reduced susceptibility of recombinant polyclonal antibodies to inhibitory anti-variable domain antibody responses.
J Immunol
; 177(6): 3782-90, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16951339